This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bidiville, J. Articles by Brunner, H. R. Search for Related Content PubMed PubMed Citation Articles by Bidiville, J. Articles by Brunner, H. R.

Hypertension, Vol 11, 166-173, Copyright © 1988 by American Heart Association

ARTICLES

Individual responses to converting enzyme inhibitors and calcium antagonists

J Bidiville, J Nussberger, G Waeber, M Porchet, B Waeber and HR Brunner
Hypertension Division, Centre Hospitalier Universitaire, Lausanne, Switzerland.

This study was designed to assess whether the acute blood pressure response of an individual hypertensive patient to a calcium antagonist or an angiotensin converting enzyme (ACE) inhibitor is a good predictor of the long-term efficacy of these drug classes in this particular patient. The concept that good responses to ACE inhibitors and calcium antagonists may be mutually exclusive was also tested. Sixteen patients were included in a randomized crossover trial of enalapril, 20 mg daily, and diltiazem, 120 mg daily, for 6 weeks each. Blood pressure was measured by ambulatory blood pressure recording. During the washout phase, the acute effect of nifedipine, 10 mg p.o., and enalaprilat, 5 mg i.v., was evaluated. Nifedipine and enalaprilat reduced blood pressure equally well. The long-term blood pressure reduction induced by enalapril and diltiazem was similar. The acute blood pressure response to a given drug was not a good predictor of the result obtained with long-term therapy. No age dependency of the antihypertensive effect of either drug class was apparent. There was no evidence that a good response to one drug excluded a similarly good response to the other.

This article has been cited by other articles:

				C. J. Zeitz, D. J. Campbell, and J. D. Horowitz Myocardial Uptake and Biochemical and Hemodynamic Effects of ACE Inhibitors in Humans Hypertension, March 1, 2003; 41(3): 482 - 487. [Abstract] [Full Text] [PDF]

				M. J Brown HYPERTENSION: Matching the right drug to the right patient in essential hypertension Heart, July 1, 2001; 86(1): 113 - 120. [Full Text] [PDF]

				D. V. Exner, D. L. Dries, M. J. Domanski, and J. N. Cohn Lesser Response to Angiotensin-Converting-Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction N. Engl. J. Med., May 3, 2001; 344(18): 1351 - 1357. [Abstract] [Full Text] [PDF]

				A. Benetos, F. Cambien, S. Gautier, S. Ricard, M. Safar, S. Laurent, P. Lacolley, O. Poirier, J. Topouchian, and R. Asmar Influence of the Angiotensin II Type 1 Receptor Gene Polymorphism on the Effects of Perindopril and Nitrendipine on Arterial Stiffness in Hypertensive Individuals Hypertension, December 1, 1996; 28(6): 1081 - 1084. [Abstract] [Full Text]

				S. G. Chrysant and The Lisinopril-Hydrochlorothiazide Group Antihypertensive Effectiveness of Low-Dose Lisinopril-Hydrochlorothiazide Combination: A Large Multicenter Study Arch Intern Med, April 11, 1994; 154(7): 737 - 743. [Abstract] [PDF]

				R. R. Townsend and O. B. Holland Combination of Converting Enzyme Inhibitor With Diuretic for the Treatment of Hypertension Arch Intern Med, June 1, 1990; 150(6): 1175 - 1183. [Abstract] [PDF]

				N. M. Kaplan Calcium Entry Blockers in the Treatment of Hypertension: Current Status and Future Prospects JAMA, August 11, 1989; 262(6): 817 - 823. [Abstract] [PDF]